Literature DB >> 21511247

The effect of cardioplegic solution-induced sodium concentration fluctuation on postoperative seizure in pediatric cardiac patients.

Jin-Tae Kim1, Young-Hee Park, Young-Eun Chang, Hyo-Jin Byon, Hee-Soo Kim, Chong-Sung Kim, Hong-Gook Lim, Woong-Han Kim, Jeong-Ryul Lee, Yong-Jin Kim.   

Abstract

BACKGROUND: Despite potential benefits of histidine-tryptophan-ketoglutarate (HTK) solution as a cardioplegic solution, it can cause hyponatremia, especially in pediatric patients. Fluctuations in the sodium concentration during cardiopulmonary bypass (CPB) can adversely affect the central nervous system. We evaluated the relationship between the cardioplegic solution, the fluctuation of sodium concentration, and the incidence of postoperative seizure in pediatric cardiac patients.
METHODS: The medical records of 628 patients were reviewed for the occurrence of a postoperative seizure, type of cardioplegic solution (HTK or del Nido solution), and intraoperative data. A change of sodium concentration exceeding 15 mmol/L (ΔNa>15) during CPB was defined as a significant fluctuation of sodium concentration.
RESULTS: Postoperative seizures were detected in 18 patients (2.9%). The ΔNa>15 was detected in 63 of 189 patients (33.3%) who received the HTK solution and in 14 of 439 patients (3.2%) who received the del Nido solution (p<0.001). The incidence of ΔNa>15 was strongly associated with postoperative seizure (odds ratio, 6.3; 95% confidence interval, 2.4 to 16.4, p=0.001). After adjusting for potential confounders, the ΔNa>15 remained significantly associated with postoperative seizure (odds ratio, 3.9; 95% confidence interval, 1.3 to 12.3, p=0.018).
CONCLUSIONS: Histidine-tryptophan-ketoglutarate solution during CPB frequently causes fluctuations of sodium concentration, usually combined with hyponatremia, which is associated with postoperative seizure. Special attention to sodium concentration is required, particularly when HTK solution is used in pediatric cardiac patients.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511247     DOI: 10.1016/j.athoracsur.2011.02.003

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Complex Cardiac Surgery on Patients with a Body Weight of Less Than 5 kg without Donor Blood Transfusion.

Authors:  Wolfgang Boettcher; Frank Dehmel; Mathias Redlin; Oliver Miera; Michele Musci; Mi-Young Cho; Joachim Photiadis
Journal:  J Extra Corpor Technol       Date:  2017-06

Review 2.  Custodiol for myocardial protection and preservation: a systematic review.

Authors:  J James B Edelman; Michael Seco; Ben Dunne; Shannon J Matzelle; Michelle Murphy; Pragnesh Joshi; Tristan D Yan; Michael K Wilson; Paul G Bannon; Michael P Vallely; Jurgen Passage
Journal:  Ann Cardiothorac Surg       Date:  2013-11

3.  Del Nido Cardioplegia-Not Just Kids Stuff.

Authors:  Linda B Mongero
Journal:  J Extra Corpor Technol       Date:  2016-06

4.  Clinical comparative analysis of histidine-tryptophan-ketoglutarate solution and St. Thomas crystalloid cardioplegia: A 12-year study from a single institution.

Authors:  Ying-Zhong Lin; Jing-Bin Huang; Xiang-Wei Li; Xian-Ming Tang; Wei-Jun Lu; Zhao-Ke Wen; Jian Liang; Dian-Yuan Li; Hao Wang
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

5.  Acute hyponatremia after cardioplegia by histidine-tryptophane-ketoglutarate--a retrospective study.

Authors:  Gregor Lindner; Bernhard Zapletal; Christoph Schwarz; Wilfried Wisser; Michael Hiesmayr; Andrea Lassnigg
Journal:  J Cardiothorac Surg       Date:  2012-06-10       Impact factor: 1.637

6.  Protective effect of HTK solution on postoperative pulmonary function in infants with CHD and PAH.

Authors:  Jindong Li; Yanhong Wu; Xudong Tian; Jiantang Wang; Mingfeng Dong; Anbiao Wang; Shengjun Ma
Journal:  Biosci Rep       Date:  2017-12-07       Impact factor: 3.840

7.  Comparative Analysis of Myocardial Protection with HTK Solution and Hypothermic Hyperkalemic Blood Solution in the Correction of Acyanogenic Congenital Cardiopathies - A Randomized Study.

Authors:  Acrisio Sales Valente; Gustavo Porto Lustosa; Lia Alves Martins Mota; Adriano Lima; Fernando Antônio de Mesquita; Aloísio Gondim; Fábio Alércio Rodrigues; Ronald Guedes Pompeu; Klébia Castelo Branco
Journal:  Braz J Cardiovasc Surg       Date:  2019-06-01

8.  Histidine-tryptophan-ketoglutarate solution decreases mortality and morbidity in high-risk patients with severe pulmonary arterial hypertension associated with complex congenital heart disease: an 11-year experience from a single institution.

Authors:  X W Li; Y Z Lin; H Lin; J B Huang; X M Tang; X M Long; W J Lu; Z K Wen; J Liang; D Y Li; X F Zhao
Journal:  Braz J Med Biol Res       Date:  2016-05-13       Impact factor: 2.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.